搜尋結果
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Keysight Announces Winners of the 2022 Innovation Challenge
ACCESSWIRE· 2 年前Keysight Technologies, Inc. (NYSE:KEYS), a leading technology company that delivers advanced ...
Eyes of the World: SPLC Delegation Tells UN Committee of Ongoing Racial Discrimination in US
ACCESSWIRE· 2 年前Terrance Winn was just 17 when he was sent to Angola in Louisiana, one of the country's ...